On the one hand, the pharmaceutical industry is willing to fund clinical trials that can follow thousands or tens of thousands of patients long enough to establish benefits on what are called hard endpointsheart attacks, for instance, or deaths from heart attacks, rather than a soft endpoint or risk factor like LDL cholesterol
Dry and Dehydrated Skin Dry skin usually feels tight, flaky, or rough after cleansing
Animal models in medicine and biology
AHK-Cu (Ala-His-Lys-Cu) is a related copper tripeptide found in human plasma that shares the His-Lys copper-binding motif but substitutes alanine for glycine at the N-terminal position, resulting in a slightly different copper coordination geometry and a distinct (though overlapping) gene expression modulation profile
Consensus Statement What they're saying: "Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in this cohort (see table)
